Goktas Aydin S - Search Results

1

Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer.

Ilhan Y, Tatli AM, Teker F, Onder AH, Kose F, Geredeli C, Karaagac M, Kaplan MA, Inanc M, Goktas Aydin S, Kargi A, Arak H, Ozturk B, Besen AA, Selvi O, Korkmaz M, Oruc Z, Bozkurt O, Bilici A, Bayram S, Dae SA, Ozdogan M, Coskun HS, Sezgin Goksu S. Ilhan Y, et al. Among authors: goktas aydin s. Int J Gynecol Cancer. 2022 Apr 4;32(4):502-507. doi: 10.1136/ijgc-2021-003165. Int J Gynecol Cancer. 2022. PMID: 35086927

2

Effect of Adjuvant Chemotherapy in Stage III Cervical Cancer Patients Treated with Concurrent Chemoradiation: A Multicenter Study.

Atci MM, Akagunduz B, Demir M, Dönmez Yilmaz B, Akin Telli T, Can O, Cil I, Goktas Aydın S, Ozyurt N, Onder AH, Selvi O, Sakin A. Atci MM, et al. Among authors: goktas aydin s. Oncol Res Treat. 2022;45(5):254-261. doi: 10.1159/000521980. Epub 2022 Jan 14. Oncol Res Treat. 2022. PMID: 35034017 Free article.

3

Real-life analysis of treatment approaches and the role of inflammatory markers on survival in patients with advanced biliary tract cancer.

Goktas Aydin S, Cakan Demirel B, Bilici A, Topcu A, Aykan MB, Kahraman S, Akbıyık I, Atci MM, Olmez OF, Yaren A, Sendur MAN, Geredeli C, Seker M, Urun Y, Karadurmus N, Aydin A. Goktas Aydin S, et al. Curr Med Res Opin. 2022 Oct;38(10):1751-1758. doi: 10.1080/03007995.2022.2108619. Epub 2022 Aug 16. Curr Med Res Opin. 2022. PMID: 35916475

4

Assessment of Prognostic Factors and Adjuvant Treatment Modalities in Adult Head and Neck Soft Tissue Sarcoma Patients Treated With Upfront Surgery.

Akagündüz B, Akin Telli T, Sezgin Goksu S, Yildirim HC, Ozer M, Göktaş Aydin S, Ozyurt N, Karacin C, Paydas S, Dogan M. Akagündüz B, et al. Among authors: goktas aydin s. Cureus. 2021 Feb 13;13(2):e13324. doi: 10.7759/cureus.13324. Cureus. 2021. PMID: 33738167 Free PMC article.

5

Triple-negative breast cancer presented with metastasis to the heart as first sign of recurrence.

Bayramgil A, Bilici A, Hamdard J, Acikgoz O, Seker M, Kilicaslan F, Koksal C, Buyukpinarbasili N, Mammadov E, Goktas Aydin S, Olmez OF, Yildiz O. Bayramgil A, et al. Among authors: goktas aydin s. Breast J. 2021 Jan;27(1):56-57. doi: 10.1111/tbj.14091. Epub 2020 Oct 18. Breast J. 2021. PMID: 33070447 No abstract available.

6

Evaluation of the efficacy and safety of nivolumab in the second- or later-line treatment of patients with locally advanced/metastatic non-small cell lung cancer in Türkiye: a retrospective multicenter non-interventional registry study.

Karadurmus N, Kaplan MA, Sendur MAN, Urun Y, Demirci U, Karaca SB, Goktas Aydin S, Aykan MB, Bilici A, Sezer A, Yilmaz U, Abali H, Yumuk PF, Degirmencioglu S, Demirkazik A, Paydas S, Mirili C, Turna H, Kargi A, Ozdogan M, Guven DC, Ozguroglu M, Kilickap S. Karadurmus N, et al. Among authors: goktas aydin s. Curr Med Res Opin. 2024 May 29:1-21. doi: 10.1080/03007995.2024.2359026. Online ahead of print. Curr Med Res Opin. 2024. PMID: 38809230

7

Associations of serum uric acid levels and anthropometric parameters with non-alcoholic fatty liver disease in healthy individuals: innovative insights from a cross-sectional study.

Aydin A, Goktas Aydin S. Aydin A, et al. Among authors: goktas aydin s. Curr Med Res Opin. 2024 Feb;40(2):209-215. doi: 10.1080/03007995.2023.2296967. Epub 2024 Jan 24. Curr Med Res Opin. 2024. PMID: 38111962

8

Predictive significance of inflammatory markers and mGPS in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.

Goktas Aydin S, Kutlu Y, Muglu H, Aydin A, Acikgoz O, Hamdard J, Karci E, Bilici A, Olmez OF, Yildiz O. Goktas Aydin S, et al. Cancer Chemother Pharmacol. 2024 Jan;93(1):71-78. doi: 10.1007/s00280-023-04592-x. Epub 2023 Sep 29. Cancer Chemother Pharmacol. 2024. PMID: 37773537

9

Impact of SPARC expression on treatment response of pembrolizumab and brain metastasis in patients with metastatic non-small cell lung cancer.

Goktas Aydin S, Bilici A, Calis E, Kutlu Y, Hamdard J, Muglu H, Fatih Olmez O, Karci E, Acikgoz O. Goktas Aydin S, et al. Int Immunopharmacol. 2023 Nov;124(Pt B):110947. doi: 10.1016/j.intimp.2023.110947. Epub 2023 Sep 22. Int Immunopharmacol. 2023. PMID: 37742369

10

Relationship between the change in tumour-infiltrating lymphocyte level and residual tumour after neoadjuvant chemotherapy in patients with locally advanced breast cancer.

Erol VB, Goktas Aydin S, Bilici A, Cakir A, Acikgoz O, Olmez OF, Basim P. Erol VB, et al. Among authors: goktas aydin s. J Chemother. 2023 Nov;35(7):662-670. doi: 10.1080/1120009X.2023.2247207. Epub 2023 Aug 20. J Chemother. 2023. PMID: 37599454

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page